CareersPipelineCollaboration RareInnovation SVGOMG The best SVG optimizer and minifier Open SVG Paste markup Demo Contribute SVGOMG provides you several options to clean and compress your SVG files. Clean up, remove, merge, minify. Upload or copy the source of your SVG to get started! 947 bytes → 267 bytes 28.19% Finance peopleAdvance treatment Skip to main contentSkip to navigationSkip to search
HNSA   ( ,  %) SEK
Quotes are delayed 15 minutes

Some non-regulatory announcements are only available in English. All announcements required under applicable law, regulation or code are available in English and Swedish.

2025

19 Dec 2025, 20:35 | Regulatory
Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation
19 Dec 2025, 11:45
Hansa Biopharma presenting at 44th Annual J.P. Morgan Healthcare Conference
16 Dec 2025, 23:07 | Regulatory
Hansa provides update on Pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) disease
15 Dec 2025, 07:00
Hansa Biopharma announce changes to strengthen European and International organisation
13 Nov 2025, 15:00
Hansa Biopharma presenting at Jefferies Global Healthcare Conference and DNB Carnegie’s 16th Annual Nordic Healthcare Conference
12 Nov 2025, 08:00
Upcoming KOL Call today: Insights on clinical practice and imlifidase Phase 3 Results
5 Nov 2025, 11:00
Hansa at Truist Securities, Stifel, and SEB Healthcare conferences
31 Oct 2025, 12:00 | Regulatory
Hansa Biopharma: Increase in number of shares and votes
Load more

E-mail

Sign up to receive updates on the latest company news and filings

Choose type

I consent to Hansa Biopharma handling my personal data. See our Privacy Policy for information about how we handle personal data.

Thank you. You will get an e-mail message to activate your subscription.